CSL Behring

About CSL Behring

CSL Behring is a global leader in developing and delivering innovative therapies for people with serious and rare diseases. With a commitment to improving the lives of patients, the company focuses on providing high-quality biotherapies derived from human plasma.

Founded in 1904, CSL Behring has a rich history of scientific excellence and a strong dedication to research and development. The company operates in over 30 countries, with its headquarters located in King of Prussia, Pennsylvania, USA, and a significant presence in the UK.

Core Activities:

• Development of life-saving therapies for conditions such as hemophilia, immunodeficiencies, and neurological disorders.
• Investment in cutting-edge research to advance the field of biotechnology.
• Collaboration with healthcare professionals and organizations to enhance patient care.

CSL Behring’s vision is to be the most trusted provider of biotherapies, ensuring that patients have access to the treatments they need. The company is dedicated to sustainability and ethical practices, striving to make a positive impact on communities around the world.

With a workforce of over 25,000 employees globally, CSL Behring fosters a culture of innovation and collaboration. The company values diversity and inclusion, recognizing that a diverse team drives creativity and success.

In summary, CSL Behring is not just a biopharmaceutical company; it is a partner in health, committed to making a difference in the lives of patients through science and compassion.